Using susceptibility-weighted images to quantify iron deposition differences in amnestic mild cognitive impairment and Alzheimer's disease

Neurology India

Volumn 61, Issue 1, 2013, Pages 26-34

  Wang, Dan ^a   Zhu, Dan ^b   Wei, Xiao Er ^a   Li, Yue Hua ^a   Li, Wen Bin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; magnetic resonance imaging; quantitative iron deposition; susceptibility weighted imaging

Indexed keywords

IRON;

ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; CAUDATE NUCLEUS; CEREBELLUM; CONTROLLED STUDY; CORPUS CALLOSUM; FEMALE; HEMISPHERE; HIPPOCAMPUS; HUMAN; IRON DEPOSITION; IRON METABOLISM; LENTICULAR NUCLEUS; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; SUSCEPTIBILITY WEIGHTED IMAGING; THALAMUS;

ALZHEIMER DISEASE; HIPPOCAMPUS; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MILD COGNITIVE IMPAIRMENT;

EID: 84875695191     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.107924     Document Type: Article

References (27)

1. Chen G, Ward BD, Xie C, Li W, Wu Z, Jones JL, et al. Classification of Alzheimer disease, mild cognitive impairment, and normal cognitive status with large-scale network analysis based on resting-state functional MR imaging. Radiology 2011;259:213-21.
2. Kantarci K, Knopman DS, Dickson DW, Parisi JE, Whitwell JL, Weigand SD, et al. Alzheimer disease: Postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements. Radiology 2008;248:210-20.
3. Stahl R, Dietrich O, Teipel SJ, Hampel H, Reiser MF, Schoenberg SO. White matter damage in Alzheimer disease and mild cognitive impairment: Assessment with diffusion-tensor MR imaging and parallel imaging techniques. Radiology 2007;243:483-92.
4. Yoshiura T, Mihara F, Kuwabara Y, Ogomori K, Kaneko K, Tanaka A, et al. MR relative cerebral blood flow mapping of Alzheimer disease: Correlation with Tc-99m HMPAO SPECT. Acad Radiol 2002;9:1383-7.
5. Zhu WZ, Zhong WD, Wang W, Zhan CJ, Wang CY, Qi JP, et al. Quantitative MR phase-corrected imaging to investigate increased brain iron deposition of patients with Alzheimer disease. Radiology 2009;253:497-504.
6. Siegelman ES, Mitchell DG, Semelka RC. Abdominal iron deposition: Metabolism, MR findings, and clinical importance. Radiology 1996;199:13-22.
7. De Rochefort L, Liu T, Kressler B, Liu J, Spincemaille P, Lebon V, et al. Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: Validation and application to brain imaging. Magn Reson Med 2010;63:194-206.
8. Haacke EM, Ayaz M, Khan A, Manova ES, Krishnamurthy B, Gollapalli L, et al. Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. J Magn Reson Imaging 2007;26:256-64.
9. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
10. Gross AL, Manly JJ, Pa J, Johnson JK, Park LQ, Mitchell MB, et al. Cortical signatures of cognition and their relationship to Alzheimer's disease. Brain Imaging Behav 2012;6:584-98.
11. Morris JC. The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 1993;43:2412-4.
12. Brink TL, Yesavage JA. Somatoform disorders: Differentiation of conversion, hypochondriacal, psychophysiologic, and related disorders. Postgrad Med 1982;72:189-94,96,98.
13. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985-92.
14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44.
15. Walhovd KB, Fjell AM, Brewer J, McEvoy LK, Fennema-Notestine C, Hagler DJ Jr, et al. Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease. AJNR Am J Neuroradiol 2010;31:347-54.
16. Juottonen K, Laakso MP, Partanen K, Soininen H. Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease. AJNR Am J Neuroradiol 1999;20:139-44.
17. Karas G, Sluimer J, Goekoop R, van der Flier W, Rombouts SA, Vrenken H, et al. Amnestic mild cognitive impairment: Structural MR imaging findings predictive of conversion to Alzheimer disease. AJNR Am J Neuroradiol 2008;29:944-9.
18. Li Y, Li J, Segal S, Wegiel J, De Santi S, Zhan J, et al. Hippocampal cerebrospinal fluid spaces on MR imaging: Relationship to aging and Alzheimer disease. AJNR Am J Neuroradiol 2006;27:912-8.
19. Kantarci K, Avula R, Senjem ML, Samikoglu AR, Zhang B, Weigand SD, et al. Dementia with Lewy bodies and Alzheimer disease: Neurodegenerative patterns characterized by DTI. Neurology 2010;74:1814-21.
20. Pfefferbaum A, Adalsteinsson E, Rohlfing T, Sullivan EV. MRI estimates of brain iron concentration in normal aging: Comparison of field-dependent (FDRI) and phase (SWI) methods. Neuroimage 2009;47:493-500.
21. Klöppel S, van Eimeren T, Glauche V, Vongerichten A, Münchau A, Frackowiak RS, et al. The effect of handedness on cortical motor activation during simple bilateral movements. Neuroimage 2007;34:274-80.
22. Ohara S, Lenz FA. Reorganization of somatic sensory function in the human thalamus after stroke. Ann Neurol 2001;50:800-3.
23. Rada P, Hernandez L, Hoebel BG. Feeding and systemic D-amphetamine increase extracellular acetylcholine in the medial thalamus: A possible reward enabling function. Neurosci Lett 2007;416:184-7.
24. Salt TE, Eaton SA. Function of non-NMDA receptors and NMDA receptors in synaptic responses to natural somatosensory stimulation in the ventrobasal thalamus. Exp Brain Res 1989;77:646-52.
25. Schenck JF, Zimmerman EA, Li Z, Adak S, Saha A, Tandon R, et al. High-field magnetic resonance imaging of brain iron in Alzheimer disease. Top Magn Reson Imaging 2006;17:41-50.
26. Constans JM, Meyerhoff DJ, Gerson J, MacKay S, Norman D, Fein G, et al. H-1 MR spectroscopic imaging of white matter signal hyperintensities: Alzheimer disease and ischemic vascular dementia. Radiology 1995;197:517-23.
27. Schuff N, Amend DL, Meyerhoff DJ, Tanabe JL, Norman D, Fein G, et al. Alzheimer disease: Quantitative H-1 MR spectroscopic imaging of frontoparietal brain. Radiology 1998;207:91-102.